| VBWG Reports |
| VBWG Reports - 2nd Quarter 2008 |
|
| June 26, 2008 |
In this issue of VBWG Reports?, our editors highlight presentations from the VBWG US Chapter Meeting held prior to the 2008 American College of Cardiology Annual Meeting. Speakers discussed novel research in cardiac cell therapy, imaging techniques, the obesity epidemic, controversies in lipid lowering, implications of antiplatelet therapy in acute coronary syndromes, and effects of cannabinoid type 1 receptor inhibition on atherosclerosis progression. For more educational resources, visit our website at www.VBWG.org. 
|
The content expresses the views of the editors and does not necessarily reflect the views or recommendations of the University of Florida College of Medicine, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc, CV Therapeutics Inc, Lilly Daiichi-Sankyo, Pfizer Inc, or the publisher. The reader is advised to consult the full prescribing information for all medications prior to use. This report is provided as a service to the medical
profession through educational grants from AstraZeneca, Boehringer Ingelheim, CV Therapeutics Inc, Lilly Daiichi-Sankyo, and Pfizer Inc. ©2008 MEDCON®. All rights reserved. |
|
Resources